Articles > Challenges & Complications

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

Important preliminary findings from the T1D Exchange multi-center surveillance study on people with T1D and COVID-19 were published this week in the Diabetes Care journal.

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

The T1D Exchange Quality Improvement Collaborative (QIC) is a T1D learning health system that includes over 10 endocrinology centers nationwide, working collaboratively on a shared goal of improving outcomes for people with T1D. The program is coordinated by the QI team at T1D Exchange in Boston.

Preliminary results of our population health surveillance study, “Type 1 Diabetes and COVID-19: Preliminary Findings from a Multi-Center Surveillance Study in the United States,” were recently published in Diabetes Care, the peer-reviewed medical journal of the American Diabetes Association. The study focuses on individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). This is the first U.S. based, multi-center study to examine patient characteristics and adverse outcomes among individuals with confirmed or suspected COVID-19.

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

A new study recently released by the National Health Service in the United Kingdom showed that people with type 1 diabetes are significantly more likely to die in the hospital setting from COVID-19 than people living with type 2 diabetes.

We're going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.

David Walton, CEO of T1D Exchange, sat down this week with Scott Benner, host of the Juicebox Podcast, to talk about their respective history with type 1 diabetes. The conversation covered a wide range of topics: Scott and Dave discussed their personal relationships with T1D, experiences in the industry, and strategies for dealing with the disease. …